Data / Research funding / Arizona / Vitalant
Vitalant: 15 NIH awards ($31.7M), fiscal years 2021 to 2026
Vitalant in Scottsdale, AZ is funded under 15 NIH awards ($31.7M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- GKT4L2JZJ622
- State
- Arizona
Awards
15 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| REDS-IV-P CENTER FOR TRANSFUSION LABORATORY STUDIES | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $7,068,966 | July 1, 2024 | June 30, 2026 | NORRIS, PHILIP J. | reporter.nih.gov |
| REDS-IV-P BRAZIL HUB | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $7,034,683 | July 1, 2024 | June 30, 2026 | reporter.nih.gov | |
| REDS-IV-P DOMESTIC HUBS | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $5,285,626 | July 1, 2024 | June 30, 2026 | CUSTER, BRIAN | reporter.nih.gov |
| Hematopoietic and Immune Development in the Human Chorion | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,664,107 | April 11, 2022 | March 31, 2027 | MUENCH, MARCUS O | reporter.nih.gov |
| Transfusion-related immunomodulation influences infectious disease outcomes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,851,251 | September 1, 2020 | June 30, 2025 | SIMMONS, GRAHAM | reporter.nih.gov |
| Modulation of Galectin-9 to Target HIV Persistence | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,602,936 | August 1, 2024 | June 30, 2029 | PILLAI, SATISH KUMAR | reporter.nih.gov |
| The impact of illness and medical treatments on the alloantibody response to platelet transfusion | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,501,864 | July 17, 2019 | June 30, 2024 | JACKMAN, RACHAEL PERETZ | reporter.nih.gov |
| Extracellular Vesicles as Biomarkers and Therapeutic Targets for Atherosclerotic Cardiovascular Disease in Persons Living with HIV | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,053,062 | June 1, 2024 | May 31, 2029 | MARQUES DE MENEZES, ERIKA GRASIELA | reporter.nih.gov |
| Innate Sensing of Cell-Free DNA and the Interferon-Mediated Control of HIV In Vivo | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,010,546 | April 1, 2023 | March 31, 2027 | PILLAI, SATISH KUMAR | reporter.nih.gov |
| Effect of blood donor sex and inter-individual variability in plasma testosterone on the transfusion effectiveness and hemostatic potential of red blood cells and platelets | NIH | National Heart, Lung, and Blood Institute | 2023 | $739,483 | January 1, 2018 | August 31, 2025 | KANIAS, TAMIR | reporter.nih.gov |
| Effect of blood donor sex and testosterone on predisposition to hemolysis in stored red blood cells | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $731,944 | January 1, 2018 | September 23, 2023 | KANIAS, TAMIR | reporter.nih.gov |
| Leveraging Stored Platelet Bioenergetics to Improve Hemostatic Function Upon Transfusion | NIH | National Heart, Lung, and Blood Institute | 2025 | $375,306 | September 1, 2025 | May 31, 2029 | THOMAS, KIMBERLY ANNE | reporter.nih.gov |
| Innate Sensing of Cell-Free DNA and the Interferon-Mediated Control of HIV In Vivo | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $277,025 | August 23, 2022 | March 31, 2023 | PILLAI, SATISH KUMAR | reporter.nih.gov |
| Possible transfusion transmitted cerebral amyloid angiopathy: evaluation of transmission of Aβ using the RADAR repository | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $262,500 | September 1, 2024 | August 31, 2026 | BUSCH, MICHAEL PAUL | reporter.nih.gov |
| Defining Drivers of mtDNA Levels in Blood Components and Their Impact on Transfusion-Related Lung Injury | NIH | National Heart, Lung, and Blood Institute | 2025 | $262,500 | September 15, 2025 | August 31, 2027 | NORRIS, PHILIP J. | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 7 | $3,135,473 | 0 | $0 |
| 2024 | 8 | $9,432,007 | 0 | $0 |
| 2023 | 4 | $2,315,796 | 0 | $0 |
| 2022 | 8 | $11,073,756 | 0 | $0 |
| 2021 | 6 | $5,764,767 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Topics of its NIH awards
- Clinical Research
- Infectious Diseases
- Genetics
- HIV/AIDS
- Aging
- Hematology
- Pediatric
- Rare Diseases
- Human Genome
- Minority Health
- Women's Health
- Stem Cell Research
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.